Novo wants to change how Wall Street owns its stock: why now

Novo Nordisk wants a bigger presence on Wall Street, and the timing may say more about the drugmaker's challenges than the listing itself. Chief executive Mike Doustdar said Novo could see advantages ...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。